હોમ › ફેફસાનું કેન્સર › ઓહાયો › Columbus
Columbus, OH માં ફેફસાનું કેન્સર ક્લિનિકલ ટ્રાયલ્સ
Columbus (લગભગ 30 માઇલની અંદર) ની સાઇટ્સ પર ફેફસાનું કેન્સર માટે 37 અભ્યાસો ભાગીદારો શોધી રહ્યા છે. કોઈ અભ્યાસ ખોલો અને જુઓ કે કોઈ જોડાઈ શકે છે અને અભ્યાસ ટીમ સાથે સંપર્ક કેવી રીતે કરવો.
અધિકૃત અભ્યાસ ટેક્સ્ટ (અંગ્રેજી)
અહીં અભ્યાસ માટે ભરતી કરી રહ્યા છો? આ પેજની ટોચ પર તેને ફીચર કરો — 30 દિવસ માટે $99 →
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
ભરતી ચાલુ છેફેઝ 3
- Mount Carmel East Hospital, Columbus
- The Mark H Zangmeister Center, Columbus
- Mount Carmel Health Center West, Columbus
- અને 3 વધુ
Prospective Multiomic Analysis in Small-Cell Lung Cancer
ભરતી ચાલુ છેઅવલોકનકારી અભ્યાસ
- Ohio State University Comprehensive Cancer Center, Columbus
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
ભરતી ચાલુ છેઅવલોકનકારી અભ્યાસસ્વસ્થ સ્વેચ્છાએ ભાગ લેનારા સ્વાગત છે
- Ohio State University Comprehensive Cancer Center, Columbus
- Mount Carmel East Hospital, Columbus
- The Mark H Zangmeister Center, Columbus
- અને 8 વધુ
Chemotherapy Combined With Immunotherapy Versus Immunotherapy Alone for Older Adults With Stage IIIB-IV Lung Cancer, The ACHIEVE Trial
ભરતી ચાલુ છેફેઝ 3
- Ohio State University Comprehensive Cancer Center, Columbus
- The Mark H Zangmeister Center, Columbus
- Mount Carmel Grove City Hospital, Grove City · 7 માઇલ દૂર
- અને 1 વધુ
Osimertinib With or Without Bevacizumab as Initial Treatment for Patients With EGFR-Mutant Lung Cancer
ભરતી ચાલુ છેફેઝ 3
- Columbus Oncology and Hematology Associates Inc, Columbus
- Grant Medical Center, Columbus
- The Mark H Zangmeister Center, Columbus
- અને 3 વધુ
Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial
ભરતી ચાલુ છેફેઝ 3
- Ohio State University Comprehensive Cancer Center, Columbus
Neladalkib (NVL-655) for TKI-naive Patients With Advanced ALK-Positive NSCLC
ભરતી ચાલુ છેફેઝ 3
- The Ohio State University, Columbus
A Study to Evaluate the Safety, Tolerability, Drug Levels, and Preliminary Efficacy of BMS-986507 Combinations in Adult Participants With Advanced Solid Tumors
ભરતી ચાલુ છેફેઝ 1/2
- Local Institution - 0102, Columbus
A Study to Compare the Combination of Navlimetostat (BMS-986504) With Pembrolizumab and Chemotherapy Versus Placebo Plus Pembrolizumab and Chemotherapy in First-line Metastatic Non-small Cell Lung Cancer Participants With Homozygous MTAP Deletion
ભરતી ચાલુ છેફેઝ 2/3
- The James Cancer Hospital and Solove Research Institute at The Ohio State University Comprehensive Cancer Center, Columbus
Study of Izalontamab Brengitecan (BMS-986507) Versus Platinum-Pemetrexed for EGFR-mutated Non-small Cell Lung Cancer After Failure of EGFR TKI Therapy (IZABRIGHT-Lung01)
ભરતી ચાલુ છેફેઝ 2/3
- The James Cancer Hospital and Solove Research Institute at The Ohio State University Comprehensive C, Columbus
Testing the Combination of an Anti-cancer Drug, Iadademstat, With Other Anti-cancer Drugs (Atezolizumab or Durvalumab) at Improving Outcomes for Small Cell Lung Cancer
ભરતી ચાલુ છેફેઝ 1/2
- Ohio State University Comprehensive Cancer Center, Columbus
Osimertinib and Tegavivint as First-Line Therapy for the Treatment of Metastatic EGFR-Mutant Non-small Cell Lung Cancer
ભરતી ચાલુ છેફેઝ 1
- Ohio State University Comprehensive Cancer Center, Columbus
A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants With Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer
ભરતી ચાલુ છેફેઝ 3
- Ohio State University, Columbus
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
ભરતી ચાલુ છેફેઝ 3
- The James Cancer Hospital and Solove Research Institute at The Ohio State University Comprehensive Cancer -T, Columbus
A Study of LY4050784 in Participants With Advanced or Metastatic Solid Tumors
ભરતી ચાલુ છેફેઝ 1
- Ohio State University Hospital, Columbus
Sotorasib in Combination With Trastuzumab Deruxtecan for the Treatment of Locally Advanced and Metastatic Non-small Cell Lung Cancer With a KRAS G12C Mutation
ભરતી ચાલુ છેફેઝ 1/2
- Ohio State University Comprehensive Cancer Center, Columbus
A Study of Sofe-M in Participants With Selected Advanced Solid Tumors
ભરતી ચાલુ છેફેઝ 1
- The Ohio State University (OSU) Wexner Medical Center, Columbus
Study to Evaluate Efficacy and Safety of Firmonertinib Compared With Investigator's Choice of EGFR Inhibitor as First-Line Treatment in Participants Who Have Locally Advanced or Metastatic NSCLC With EGFR P-Loop and Alpha C-Helix Compressing (PACC) Uncommon Mutations
ભરતી ચાલુ છેફેઝ 3
- Ohio State University Hospitals, Columbus
Testing Proton Craniospinal Radiation Therapy Versus the Usual Radiation Therapy for Leptomeningeal Metastasis, RADIATE-LM Trial
ભરતી ચાલુ છેફેઝ 3
- Ohio State University Comprehensive Cancer Center, Columbus
Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small Cell Lung Cancer
ભરતી ચાલુ છેફેઝ 3
- Riverside Methodist Hospital, Columbus
- Grant Medical Center, Columbus
- Doctors Hospital, Columbus
- અને 3 વધુ
A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors
ભરતી ચાલુ છેફેઝ 1/2
- The Ohio State University Comprehensive Cancer Center, Columbus
Study of XmAb®819 in Subjects With Advanced Clear Cell Renal Cell Carcinoma
ભરતી ચાલુ છેફેઝ 1
- Xencor Investigative Site, Columbus
Evaluation of Geriatric Assessment and Management for Older Adults With Non-small Cell Lung Cancer Receiving Chemotherapy Radiation Therapy
ભરતી ચાલુ છેસ્વસ્થ સ્વેચ્છાએ ભાગ લેનારા સ્વાગત છે
- Ohio State University Comprehensive Cancer Center, Columbus
Papaverine in Combination With Chemoradiation for the Treatment of Stage II-III Non-small Cell Lung Cancer
ભરતી ચાલુ છેફેઝ 1
- Ohio State University Comprehensive Cancer Center, Columbus
Autologous LN-145 in Patients With Metastatic Non-Small-Cell Lung Cancer
ભરતી ચાલુ છેફેઝ 2
- Ohio State University Comprehensive Cancer Center, Columbus
A Study to Evaluate the Safety and Efficacy of Mesothelin-Targeting Logic-gated CAR T, in Participants With Solid Tumors That Express MSLN and Have Lost HLA-A*02 Expression
ભરતી ચાલુ છેફેઝ 1/2
- The Ohio State University Comprehensive Cancer Center, Columbus
Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)
ભરતી ચાલુ છેફેઝ 2
- Mount Carmel East Hospital, Columbus
- The Mark H Zangmeister Center, Columbus
- Mount Carmel Grove City Hospital, Grove City · 7 માઇલ દૂર
- અને 2 વધુ
A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements
ભરતી ચાલુ છેફેઝ 1/2
- The Ohio State University Wexner Medical Center, Columbus
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)
ભરતી ચાલુ છેફેઝ 2
- Ohio State University Comprehensive Cancer Center, Columbus
Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)
ભરતી ચાલુ છેફેઝ 2/3
- Columbus Oncology and Hematology Associates Inc, Columbus
- Riverside Methodist Hospital, Columbus
- Grant Medical Center, Columbus
- અને 7 વધુ
Safety and Tolerability of TNG456 Alone and in Combination With Abemaciclib in Patients With Solid Tumors With MTAP Loss
ભરતી ચાલુ છેફેઝ 1/2
- Ohio State University Comprehensive Cancer Center, Columbus
Temozolomide and Atezolizumab for Subsequent Line for the Treatment of Metastatic or Recurrent Small Cell Lung Cancer
ભરતી ચાલુ છેફેઝ 2
- Ohio State University Comprehensive Cancer Center, Columbus
Delayed or Upfront Brain RAdiotherapy in Treatment naïve Lung Cancer Patients With Asymptomatic or Minimally Symptomatic Brain Metastases and ALK rEarrangements
ભરતી ચાલુ છેફેઝ 1/2
- Ohio State University Comprehensive Cancer Center, Columbus
Telephone-based Physical Activity Coaching or Self Monitored Physical Activity to Improve Physical Function in Older Adults Who Are Undergoing Surgery for Lung Cancer and Their Caregivers
ભરતી ચાલુ છેસ્વસ્થ સ્વેચ્છાએ ભાગ લેનારા સ્વાગત છે
- Ohio State University, Columbus
PBF-1129 and Nivolumab for the Treatment of Recurrent or Metastatic Non-Small Cell Lung Cancer
ભરતી ચાલુ છેફેઝ 1
- Ohio State University Comprehensive Cancer Center, Columbus
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
ભરતી ચાલુ છેઅવલોકનકારી અભ્યાસ
- Massive Bio SYNERGY-AI site, Columbus
A Study to Evaluate the Safety and Efficacy of A2B395, an Allogeneic Logic-gated CAR T, in Participants With Solid Tumors That Express EGFR and Have Lost HLA-A*02 Expression
ભરતી ચાલુ છેફેઝ 1/2
- The Ohio State University, Columbus
અન્ય શહેરોમાં ફેફસાનું કેન્સર ટ્રાયલ્સ
- Houston, TX78 અભ્યાસો
- Boston, MA62 અભ્યાસો
- New York City, NY60 અભ્યાસો
- Los Angeles, CA45 અભ્યાસો
- Arlington, VA41 અભ્યાસો
- Washington, DC41 અભ્યાસો
- Chicago, IL41 અભ્યાસો
- Nashville, TN40 અભ્યાસો
- Baltimore, MD40 અભ્યાસો
- St. Louis, MO39 અભ્યાસો
- Philadelphia, PA36 અભ્યાસો
- Seattle, WA33 અભ્યાસો
Columbus માં અન્ય અભ્યાસો
- નોન-સ્મોલ સેલ લંગ કેન્સર56 અભ્યાસો
- સ્તન કેન્સર39 અભ્યાસો
- ઓવેરિયન કેન્સર39 અભ્યાસો
- કેન્સર (બધા પ્રકાર)38 અભ્યાસો
- એક્યુટ માયલોઇડ લ્યુકેમિયા35 અભ્યાસો
- ક્રોનિક લિમ્ફોસાઈટિક લ્યુકેમિયા28 અભ્યાસો
- મેટાસ્ટેટિક કેન્સર27 અભ્યાસો
- એન્ડોમેટ્રિયલ કેન્સર25 અભ્યાસો
- કોલોરેક્ટલ કેન્સર24 અભ્યાસો
- પ્રોસ્ટેટ કેન્સર24 અભ્યાસો
- મલ્ટિપલ માયલોમા24 અભ્યાસો
- મેલેનોમા21 અભ્યાસો
ClinicalTrials.gov પરથી, તારીખ 5 ઑક્ટો, 2026 ના ડેટા સાથે. દરેક અભ્યાસની પોતાની પાત્રતા શરતો હોય છે; અભ્યાસ ટીમ નક્કી કરે છે કે કોઈ જોડાઈ શકે છે કે નહીં.